Room Temperature Synthesis and Antibacterial Activity of New Sulfonamides Containing N, N-Diethyl-Substituted Amido Moieties

被引:6
作者
Ajani, Olayinka O. [1 ]
Familoni, Oluwole B. [2 ]
Wu, Feipeng [3 ]
Echeme, Johnbull O. [1 ]
Zheng Sujiang [4 ]
机构
[1] Covenant Univ, Dept Chem, PMB 1023, Ota, Ogun State, Nigeria
[2] Univ Lagos, Dept Chem, Akoka 100001, Lagos State, Nigeria
[3] Chinese Acad Sci, Tech Inst Phys & Chem, New Funct Polymer Mat Grp, Beijing 100190, Peoples R China
[4] Chinese Acad Sci, Tech Inst Phys & Chem, Test Ctr Antimicrobial Mat, Beijing 100190, Peoples R China
关键词
D O I
10.1155/2012/367815
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Sulfonamide drugs which have brought about an antibiotic revolution in medicine are associated with a wide range of biological activities. We have synthesized a series of a-tolylsulfonamide, 1-11 and their substituted N, N-diethyl-2-(phenylmethylsulfonamido) alkanamide derivatives, 12-22 in improved and excellent yields in aqueous medium at room temperature through highly economical synthetic routes. The chemical structures of the synthesized compounds 1-22 were confirmed by analytical and spectral data such as IR, H-1-and C-13-NMR, andmass spectra. The in vitro antibacterial activity of these compounds along with standard clinical reference, streptomycin, was investigated on two key targeted organisms. It was observed that 1-(benzylsulfonyl) pyrrolidine-2-carboxylic acid, 2 emerged as the most active compound against Staphylococcus aureus at MIC value of 1.8 mu g/mL while 4-(3-(diethylamino)-3-oxo-2-(phenylmethylsulfonamido) propyl) phenyl phenylmethanesulfonate, 22 was the most active sulfonamide scaffold on Escherichia coli at MIC value of 12.5 mu g/mL.
引用
收藏
页数:13
相关论文
共 73 条
[1]   Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX [J].
Abbate, F ;
Casini, A ;
Owa, T ;
Scozzafava, A ;
Supuran, CT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) :217-223
[2]  
Adeniyi B A, 1996, Afr J Med Med Sci, V25, P221
[3]   N-Glycine-sulfonamides as potent dual orexin 1/orexin 2 receptor antagonists [J].
Aissaoui, Hamed ;
Koberstein, Ralf ;
Zumbrunn, Cornelia ;
Gatfield, John ;
Brisbare-Roch, Catherine ;
Jenck, Francois ;
Treiber, Alexander ;
Boss, Christoph .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (21) :5729-5733
[4]  
Ajani O. O., 2009, Canadian Journal of Pure & Applied Sciences, V3, P983
[5]   Microwave-Assisted Synthesis and Evaluation of Antimicrobial Activity of 3-{3-(s-Aryl and s-Heteroaromatic)acryloyl}-2H-chromen-2-one Derivatives [J].
Ajani, Olayinka O. ;
Nwinyi, Obinna C. .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2010, 47 (01) :179-187
[6]   Microwave assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives [J].
Ajani, Olayinka O. ;
Obafemi, Craig A. ;
Nwinyi, Obinna C. ;
Akinpelu, David A. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (01) :214-221
[7]   Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 Ligands [J].
Ali, Akbar ;
Reddy, G. S. Kiran Kumar ;
Cao, Hong ;
Anjum, Saima Ghafoor ;
Nalam, Madhavi N. L. ;
Schiffer, Celia A. ;
Rana, Tariq M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (25) :7342-7356
[8]  
Anand N., 2010, BURGERS MED CHEM DRU, P481
[9]   Emerging infectious diseases of plants: pathogen pollution, climate change and agrotechnology drivers [J].
Anderson, PK ;
Cunningham, AA ;
Patel, NG ;
Morales, FJ ;
Epstein, PR ;
Daszak, P .
TRENDS IN ECOLOGY & EVOLUTION, 2004, 19 (10) :535-544
[10]   Synthesis, biological evaluation and SAR of sulfonamide 4-methoxychalcone derivatives with potential antileishmanial activity [J].
Andrighetti-Frohner, Carla R. ;
de Oliveira, Kely N. ;
Gaspar-Silva, Daniela ;
Pacheco, Leticia K. ;
Joussef, Antonio C. ;
Steindel, Mario ;
Simoes, Claudia M. O. ;
de Souza, Alessandra M. T. ;
Magalhaes, Uiaran O. ;
Afonso, Ilidio F. ;
Rodrigues, Carlos R. ;
Nunes, Ricardo J. ;
Castro, Helena C. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (02) :755-763